Cyclic guanosine monophosphate modulates accumulation of phosphodiesterase 5 inhibitors in human platelets

Sildenafil and tadalafil are widely-used phosphodiesterase 5 (PDE5) inhibitors for which no clear dose-response relationship could be established. Using isolated and/or recombinant PDE5, it has been demonstrated that cGMP can increase the affinity of this enzyme for sildenafil and tadalafil. We thus...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Bajraktari-Sylejmani, Gzona (VerfasserIn) , Burhenne, Jürgen (VerfasserIn) , Bugert, Peter (VerfasserIn) , Haefeli, Walter E. (VerfasserIn) , Weiß, Johanna (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 1 December 2017
In: Biochemical pharmacology
Year: 2017, Jahrgang: 145, Pages: 54-63
ISSN:1873-2968
DOI:10.1016/j.bcp.2017.08.026
Online-Zugang:Verlag, Volltext: http://dx.doi.org/10.1016/j.bcp.2017.08.026
Verlag, Volltext: http://www.sciencedirect.com/science/article/pii/S0006295217306111
Volltext
Verfasserangaben:Gzona Bajraktari, Jürgen Burhenne, Peter Bugert, Walter Emil Haefeli, Johanna Weiss

MARC

LEADER 00000caa a2200000 c 4500
001 1575076462
003 DE-627
005 20230427042902.0
007 cr uuu---uuuuu
008 180515s2017 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.bcp.2017.08.026  |2 doi 
035 |a (DE-627)1575076462 
035 |a (DE-576)505076462 
035 |a (DE-599)BSZ505076462 
035 |a (OCoLC)1341009482 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Bajraktari-Sylejmani, Gzona  |e VerfasserIn  |0 (DE-588)1152395823  |0 (DE-627)1013994760  |0 (DE-576)499867106  |4 aut 
245 1 0 |a Cyclic guanosine monophosphate modulates accumulation of phosphodiesterase 5 inhibitors in human platelets  |c Gzona Bajraktari, Jürgen Burhenne, Peter Bugert, Walter Emil Haefeli, Johanna Weiss 
264 1 |c 1 December 2017 
300 |a 10 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 15.05.2018 
520 |a Sildenafil and tadalafil are widely-used phosphodiesterase 5 (PDE5) inhibitors for which no clear dose-response relationship could be established. Using isolated and/or recombinant PDE5, it has been demonstrated that cGMP can increase the affinity of this enzyme for sildenafil and tadalafil. We thus hypothesized that in cells expressing the nitric oxide - soluble guanylyl cyclase - cyclic guanosine monophosphate - PDE5 (NO-sGC-cGMP-PDE5) pathway such as platelets, the presence of NO increases the intracellular cGMP content and thus promotes the intracellular accumulation of sildenafil or tadalafil. As a cell model, isolated and washed human platelets were used. Platelet suspensions were incubated with sildenafil or tadalafil at different concentrations and for various time intervals with or without an NO donor to increase intraplatelet cGMP concentrations. Intracellular sildenafil or tadalafil was quantified by ultra-performance liquid chromatography tandem mass spectrometry and intracellular cGMP by an enzyme-linked immunosorbent assay. Sildenafil accumulated in platelets with an up to 4-fold higher accumulation when platelets were pretreated with an NO donor (p<.0001). Accumulation of tadalafil in platelets was even higher, whereas the increase was 2-fold when an NO donor was present (p<.001). This accumulation was time-dependent and happened concomitantly with a rise in intracellular cGMP. Our data demonstrate that intracellular cGMP increases intracellular PDE5 inhibitor concentrations most likely by raising the affinity of these compounds for PDE5. These findings suggest that PDE5 inhibitor action in humans is critically influenced by modulators of the activity of the NO pathway. 
650 4 |a cGMP 
650 4 |a LC-MS/MS 
650 4 |a Platelets 
650 4 |a Sildenafil 
650 4 |a Tadalafil 
700 1 |a Burhenne, Jürgen  |d 1963-  |e VerfasserIn  |0 (DE-588)1034228889  |0 (DE-627)745126987  |0 (DE-576)381858197  |4 aut 
700 1 |a Bugert, Peter  |d 1964-  |e VerfasserIn  |0 (DE-588)1025332342  |0 (DE-627)722074018  |0 (DE-576)370212169  |4 aut 
700 1 |a Haefeli, Walter E.  |d 1958-  |e VerfasserIn  |0 (DE-588)124572359  |0 (DE-627)656806141  |0 (DE-576)340514221  |4 aut 
700 1 |a Weiß, Johanna  |e VerfasserIn  |0 (DE-588)1050230906  |0 (DE-627)783666322  |0 (DE-576)404441114  |4 aut 
773 0 8 |i Enthalten in  |t Biochemical pharmacology  |d Amsterdam [u.a.] : Elsevier Science, 1958  |g 145(2017), Seite 54-63  |h Online-Ressource  |w (DE-627)30631777X  |w (DE-600)1496199-4  |w (DE-576)081952929  |x 1873-2968  |7 nnas  |a Cyclic guanosine monophosphate modulates accumulation of phosphodiesterase 5 inhibitors in human platelets 
773 1 8 |g volume:145  |g year:2017  |g pages:54-63  |g extent:10  |a Cyclic guanosine monophosphate modulates accumulation of phosphodiesterase 5 inhibitors in human platelets 
856 4 0 |u http://dx.doi.org/10.1016/j.bcp.2017.08.026  |x Verlag  |x Resolving-System  |3 Volltext 
856 4 0 |u http://www.sciencedirect.com/science/article/pii/S0006295217306111  |x Verlag  |3 Volltext 
951 |a AR 
992 |a 20180515 
993 |a Article 
994 |a 2017 
998 |g 1050230906  |a Weiß, Johanna  |m 1050230906:Weiß, Johanna  |d 910000  |d 910100  |e 910000PW1050230906  |e 910100PW1050230906  |k 0/910000/  |k 1/910000/910100/  |p 5  |y j 
998 |g 124572359  |a Haefeli, Walter E.  |m 124572359:Haefeli, Walter E.  |d 910000  |d 910100  |e 910000PH124572359  |e 910100PH124572359  |k 0/910000/  |k 1/910000/910100/  |p 4 
998 |g 1025332342  |a Bugert, Peter  |m 1025332342:Bugert, Peter  |d 60000  |d 63500  |e 60000PB1025332342  |e 63500PB1025332342  |k 0/60000/  |k 1/60000/63500/  |p 3 
998 |g 1034228889  |a Burhenne, Jürgen  |m 1034228889:Burhenne, Jürgen  |d 910000  |d 910100  |e 910000PB1034228889  |e 910100PB1034228889  |k 0/910000/  |k 1/910000/910100/  |p 2 
998 |g 1152395823  |a Bajraktari-Sylejmani, Gzona  |m 1152395823:Bajraktari-Sylejmani, Gzona  |d 910000  |d 910100  |e 910000PB1152395823  |e 910100PB1152395823  |k 0/910000/  |k 1/910000/910100/  |p 1  |x j 
999 |a KXP-PPN1575076462  |e 3009347952 
BIB |a Y 
SER |a journal 
JSO |a {"title":[{"title":"Cyclic guanosine monophosphate modulates accumulation of phosphodiesterase 5 inhibitors in human platelets","title_sort":"Cyclic guanosine monophosphate modulates accumulation of phosphodiesterase 5 inhibitors in human platelets"}],"name":{"displayForm":["Gzona Bajraktari, Jürgen Burhenne, Peter Bugert, Walter Emil Haefeli, Johanna Weiss"]},"id":{"doi":["10.1016/j.bcp.2017.08.026"],"eki":["1575076462"]},"physDesc":[{"extent":"10 S."}],"origin":[{"dateIssuedDisp":"1 December 2017","dateIssuedKey":"2017"}],"relHost":[{"origin":[{"dateIssuedDisp":"1958-","publisher":"Elsevier Science","publisherPlace":"Amsterdam [u.a.]","dateIssuedKey":"1958"}],"physDesc":[{"extent":"Online-Ressource"}],"disp":"Cyclic guanosine monophosphate modulates accumulation of phosphodiesterase 5 inhibitors in human plateletsBiochemical pharmacology","language":["eng"],"title":[{"title_sort":"Biochemical pharmacology","title":"Biochemical pharmacology"}],"pubHistory":["1.1958 -"],"type":{"media":"Online-Ressource","bibl":"periodical"},"note":["Gesehen am 21.02.20"],"part":{"volume":"145","text":"145(2017), Seite 54-63","pages":"54-63","year":"2017","extent":"10"},"recId":"30631777X","id":{"zdb":["1496199-4"],"eki":["30631777X"],"issn":["1873-2968"]}}],"person":[{"display":"Bajraktari-Sylejmani, Gzona","roleDisplay":"VerfasserIn","role":"aut","given":"Gzona","family":"Bajraktari-Sylejmani"},{"display":"Burhenne, Jürgen","given":"Jürgen","roleDisplay":"VerfasserIn","role":"aut","family":"Burhenne"},{"display":"Bugert, Peter","role":"aut","roleDisplay":"VerfasserIn","given":"Peter","family":"Bugert"},{"display":"Haefeli, Walter E.","roleDisplay":"VerfasserIn","role":"aut","given":"Walter E.","family":"Haefeli"},{"family":"Weiß","display":"Weiß, Johanna","given":"Johanna","role":"aut","roleDisplay":"VerfasserIn"}],"language":["eng"],"note":["Gesehen am 15.05.2018"],"recId":"1575076462","type":{"media":"Online-Ressource","bibl":"article-journal"}} 
SRT |a BAJRAKTARICYCLICGUAN1201